Sinovac CoronaVac (COVID-19 Vaccine)


We currently can help with the purchase of Sinovac CoronaVac, which obtained conditional market approval by China’s National Medical Products Administration on February 5th, 2021.

It is an inactivated COVID-19 vaccine developed by domestic drugmaker Sinovac Biotech. Sinovac Life Sciences Co Ltd on February 3rd filed an application for conditional market approval of CoronaVac, which was granted on the basis of the vaccine’s overseas phase-3 clinical trials for two months.

The Sinovac vaccine is regarded as an affordable and easily distributed (it does not require expensive cold storage) vaccine. From this January, several countries successively approved the emergency use of the Sinovac vaccine locally, and with the recent conditional market approval in China, the demand is high.
Documents needed:
-Purchase order from Ministry of Public Health or CDC (provincial or above, preferably national);
-Letter of Intent/ Procurement Letter;
  -Bank statement (fund certificate).
MOQ: 500.000 doses.
Product information:
-Two doses per person, 14 days interval.
-1 box (1 dose): 10cm*6cm*2.5cm, weight is below 50gram.
-50w boxes: volume is around 75 cubic meters, weight is around 25 tons.
-Storage temperature: 2-8ºC
Note that there is no 3rd party involved and the approval will take around 1 week. Sinovac will submit the procurement to the Department of Commerce and Ministry of Health, followed by an audit from the National Epidemic Prevention Materials Vaccine Group. After the approval by the State, it will be submitted to the Foreign Ministry, which will entrust Sinovac with the official stamp of PRC’s Embassy and so obtain authorization.
If you have any questions or would like to put in an order, please do not hesitate to contact us via



There are no reviews yet.

Be the first to review “Sinovac CoronaVac (COVID-19 Vaccine)”